Form 4: Alignment Healthcare President Sells 30,000 Shares

Alignment Healthcare President Dawn Maroney sold 30,000 shares of common stock via a pre-arranged 10b5-1 trading plan.

Summary

• Dawn Maroney, President of Alignment Healthcare, Inc., sold 30,000 shares of common stock.
• The transaction occurred on June 15, 2026.
• The shares were sold at a weighted-average price of $19.5475 per share.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on May 22, 2025.
• Following the transaction, the reporting person retains beneficial ownership of 947,313 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was pre-planned and represents a small portion of the executive's total holdings.

Positives

• The sale was conducted under a pre-established Rule 10b5-1 plan, which is a standard mechanism for executives to sell shares without concerns regarding insider trading.

Negatives

• The transaction represents a reduction in the executive's direct equity stake in the company.

Risks

• Insider selling can sometimes be perceived negatively by the market as a signal of management's view on the company's near-term valuation.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales under 10b5-1 plans are routine corporate governance events and generally do not reflect a change in company strategy or fundamental outlook.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for C-suite executives to manage personal liquidity while maintaining compliance with SEC regulations.

Stakeholder Impact

• Minimal impact expected as the sale was executed via a pre-planned trading program.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Alignment Healthcare, ALHC, Insider Selling, Form 4, Dawn Maroney, Equity Transaction